Put companies on watchlist
Cannovum AG
ISIN: DE000A2LQU21
WKN: A2LQU2
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Cannovum AG · ISIN: DE000A2LQU21 · EQS - Company News (50 News)
Country: Germany · Primary market: Germany · EQS NID: 1459835
10 October 2022 09:48AM

Cannovum AG: Joint research project with Macromedia University on the future of investor communication


EQS-News: Cannovum AG / Key word(s): Miscellaneous
Cannovum AG: Joint research project with Macromedia University on the future of investor communication

10.10.2022 / 09:48 CET/CEST
The issuer is solely responsible for the content of this announcement.


Cannovum AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21), one of the market leaders in the medical cannabis market, launches the first research project on the future of investor communication with the renowned Macromedia University.

 

The global pandemic presented new challenges regarding financial communications.  Intensive communication between shareholders and public companies is becoming increasingly important, particularly during economically volatile times. Numerous meetings are now conducted via video conferencing while new digital channels from TikTok to Metaverse open up enormous opportunities for addressing digitally oriented shareholders.

 

Cannovum AG, as one of the leaders in the emerging medical cannabis market, will explore new avenues of investor communication. In October 2022, Cannovum AG will launch a dedicated research project with master's students from Macromedia University's Media & Communications Management program to scientifically develop new ways of addressing and engaging with shareholders. The focus is particularly on strategic alignment with digital platforms such as Discord and Metaverse.

 

"This is a project to our liking: practice-relevant, future-oriented, digital. Just like us." comments Professor Dr. FC Wachs from the Berlin Campus of Macromedia University. Pia Marten, CEO Cannovum AG: "The cooperation with Macromedia University underlines our innovation claim as market leader in the industry. The upcoming legalization requires new, intelligent stakeholder communication."

 

Cannovum AG is already optimally prepared for the coming legalization of recreational cannabis. New markets create new customers and therefore also demand new forms of investor communication.

 

The Macromedia University of Applied Sciences has about 4,750 students and more than 140 professors at eight locations in the German cities of Munich, Stuttgart, Frankfurt, Freiburg, Cologne, Hamburg, Leipzig and Berlin. The bachelor's and master's degree programs cover the entire spectrum of management, media and art/creativity. The Macromedia University of Applied Sciences cooperates with more than 500 practical partners across all subjects. These include well-known names such as the software company Microsoft, the cult car brand Mini and the media group RTL.

 

For more information about Cannovum AG and Cannovum Health eG, in which the operating business with medical cannabis of Cannovum AG is consolidated, please visit: https://cannovum.de/investor-relations

 

 

Contact:

Klaus Madzia, IR & PR, Cannovum AG

Phone +49 30 3982 163 62, klaus.madzia@cannovum.com

 

 

Cannovum AG is the first publicly listed German fully licensed cannabis company. The shares are traded on the stock exchanges in Düsseldorf, Munich, Berlin, Hamburg and gettex. Through its subsidiary Cannovum Health eG, it is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based in Berlin. The company focuses on the importation of high-quality cannabinoid precursors, medical-scientific education and nationwide distribution for simplified and equitable access to cannabis-based therapies.

 

For more information visit www.cannovum.de

 



10.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cannovum AG
Rheinsberger Str. 76/77
10115 Berlin
Germany
Phone: +49 (0)30 3982 16360
E-mail: ir@cannovum.com
Internet: www.cannovum.com
ISIN: DE000A2LQU21
WKN: A2LQU2
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich
EQS News ID: 1459835

 
End of News EQS News Service

1459835  10.10.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1459835&application_name=news&site_id=boersengefluester_html

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.